drugset / Trial / NCT06246175

A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

NCT06246175

Phase 1 Completed 32 enrolled Fujian Shengdi Pharmaceutical Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess how fast HRS9531 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.

Timeline

Start
2024-02-28
Primary completion
2025-09-02
Completion
2025-09-02

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS9531 Unknown